Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Regenerative Medicine 2020

Regenerative Medicine 2020

About Conference


Conference Series LLC Ltd is a renowned organization that organizes highly notable conferences around the world. Regenerative Medicine 2020 welcomes all the associates around the globe which is going to be held during August 24-25, 2020 in Vancouver, Canada

 

Conference Name Place Date

Regenerative Medicine 2020

Vancouver, Canada August 24-25, 2020

 

Regenerative Medicine 2020 welcomes the researchers and developers, professionals who are studying or analyzing in the fields of Stem Cell, Genetics, Regenerative Medicine, Cell Biology, etc., and other associated organizations to participate in the event and grasp knowledge about the recent researches regarding stem cell and regenerative medicine and their analysis. This conference will consist of the keynote talks, session talks, oral presentations, poster presentations, B2B networking etc. The aim of this global conference is to promote the recent advances in Stem Cell Therapy Research with its applications as well as the cell and gene therapy which stands as the new therapeutic approaches. The conference will also support and motivate the young researches in the fields of Stem Cells and Genetics Research to meet the new advancements.

Why to Attend:

Regenerative Medicine 2020 is a global platform to discuss and learn about Stem Cell Research, Regenerative Medicine its Current therapies and future research directions. The Conference includes B2B Meetings, Panel Discussions, Industry expert interactions, Roundtable meetings, Best Poster awards, and Best Oral presentation awards, Young Researcher Forums, e-Poster presentations, Video presentations by the experts from both Industry & Academic.

Target Audience 

  • Gene Therapy Scientists
  • Stem Cell Researchers, developers and Investigators
  • Emeritus and Academic professors
  • Cell Biologists
  • Genetic scientists
  • Molecular Biologists
  • Regenerative Medicine researchers
  • Business Entrepreneurs
  • Drug Manufacturing Companies
  • Stem cell Developers and Investigators
  • Tissue Engineers
  • Wound care Specialists
  • Academic Professionals
  • Anatomical Researchers
  • Oncologists
  • Neurologists
  • Immunologists
  • Ophthalmologists

 

Sessions & Tracks

Track 1: Cell Signaling & Cell Communication

Cell signaling is part of any communication process that governs basic activities of cells and coordinates all cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity, as well as normal tissue homeostasis. Errors in signaling interactions and cellular information processing are responsible for diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, diseases may be treated more effectively and, theoretically, artificial tissues may be created.

Track 2: Regenerative Medicine and Cell Therapy

Cell therapy and tissue engineering, which involve collecting cells from either the patient or a donor and introducing them into injured tissues or organs, sometimes after modifying their properties, offer promising solutions for regenerative medicine. Indeed, so promising are these therapies that current research has shifted from organ growth to cell therapy. The range of therapeutic applications is wide, including cardiac insufficiency, atherosclerosis, cartilage defects, bone repair, burns, diabetes and liver or bladder regeneration.

Track 3: Cell and Tissue Therapy in Regenerative Medicine

The objective of cell therapy is to restore the lost function rather than produce a new organ, which could cause duplicity and undesirable effects. Several resources of cells can be used to restore the damaged tissue, such as resident stem cells, multi potent adult progenitor cells or embryonic stem cells.

Track 4: Stem Cells & Types

Stem cells: An undifferentiated cell of a multicellular organism which is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation. Stem cells have the ability to differentiate into specific cell types. The two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent that are restricted to becoming a more limited population of cells.

Track 5: Tumor cell science

Cancer cells are cells gone wrong in other words, they no longer respond to many of the signals that control cellular growth and death. Cancer cells originate within tissues and, as they grow and divide, they diverge ever further from normalcy. Over time, these cells become increasingly resistant to the controls that maintain normal tissue and as a result, they divide more rapidly than their progenitors and become less dependent on signals from other cells. Cancer cells even evade programmed cell death, despite the fact that their multiple abnormalities would normally make them prime targets for apoptosis. In the late stages of cancer, cells break through normal tissue boundaries and metastasize to new sites in the body.

Track 6: Stem Cell Therapies & Biomarkers

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Stem cell markers are genes and their protein products used by scientists to isolate and identify stem cells. Stem cells can also be identified by functional assays. Molecular biomarkers serve as valuable tools to classify and isolate embryonic stem cells (ESCs) and to monitor their differentiation state by antibody-based techniques. ESCs can give rise to any adult cell type and thus offer enormous potential for regenerative medicine and drug discovery

Track 7: Personalized Medicine

Personalized medicine, precision medicine, or theranostics is a medical model that separates people into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease.

Track 8: Embryonic stem cells

 Embryonic stem cells are stem cells derived from the undifferentiated inner mass cells of a human embryo. Embryonic stem cells are pluripotent that means they are able to grow into all derivatives of the three primary germ layers: ectoderm, endoderm and mesoderm.

Track 9: Anti-aging medicine role of stem cells

Anti-aging medicines are unique because they use a patient's own stem cells and can be transplanted where they are needed. Treatments replenish the body with a fresh supply of concentrated stem cells to allow the repair and rejuvenation process in all organs, including skin

Track 10 : Diseases and Stem Cell Treatment

Stem cell research is perhaps the most exciting medical technology of the 21st Century. Stem cells hold the promise of treatments and cures for more than 70 major diseases and conditions that affect millions of people, including diabetes, Parkinson's, Alzheimer's, cancer, multiple sclerosis, Lou Gehrig's Disease (ALS), spinal cord injuries, blindness, and HIV/AIDS. 

Track 11:  Regenerative Medicine and Disease Therapeutics

Stem Cells applications in Regenerative Medicine and Disease Therapeutics is the most recent and emerging branch of medical science, deals with functional restoration of tissues or organs for the patient suffering from severe injuries or chronic disease

Track 12:  Tissue Engineering

Tissue engineering is the use of a combination of cells, engineering, and materials methods, and suitable biochemical and physicochemical factors to improve or replace biological tissues. Tissue engineering involves the use of a tissue scaffold for the formation of new viable tissue for a medical purpose.

Track 13:  Scaffolds Used In Tissue Engineering

Scaffolds are the bio materials utilized in the human body to recover the harmed tissues by consolidating cells from the body. Biodegradability and biocompatibility are the most significant highlights for a platform to be utilized in tissue designing. The materials ought to contain adequate porosity, a legitimate design and a satisfactory pore size are important to encourage cell seeding and dissemination all through the entire structure of both separating cells and supplements. Platforms are of over the top significance in clinical medication, it is a pending field and normally related with conditions including organ ailment or disappointment. Tissue Engineering includes the utilization of a Scaffold for the development of new plausible tissue for a medicinal reason.

Track 14:  Applications Of Tissue Engineering

The applications of Tissue Engineering have been useful in conquering issues of any harmed tissues. Bone Tissue Engineering-Bones are made out of collagen and have the property to recover, fix in light of damage like bone tissue designing, challenges likewise lies with ligament tissue building. Advances in the investigation of organic frameworks dependent on their auxiliary and utilitarian conduct are useful in vitro examinations. Tissue Engineering utilizes nature as a hotspot for frameworks either from the characteristic or manufactured starting point. These platforms cells are utilized for the assurance of cell destiny, regarding multiplication, separation and movement. This survey is to investigate the forefront of Tissue Engineering and its application in the different fields.

Track 15:  Recent advances in stem cell biology

A variety of stem cells with different origins and differentiation potency are expected to cure numerous degenerative diseases, chronic diseases and acute tissue injuries. Recent advances in stem cell biology and stem cell engineering provide new avenue for pluripotent stem cells, including embryonic stem cells, induced pluripotent stem cells, and directly converted stem-like cells, which are essential resources for disease modeling, drug screening, and cell therapeutics for regenerative medicine.

Track 16:  Anti-aging medicine role of stem cells

Anti-aging medicines are unique because they use a patient's own stem cells and can be transplanted where they are needed. Treatments replenish the body with a fresh supply of concentrated stem cells to allow the repair and rejuvenation process in all organs, including skin

Track 17:  Tissue repair and Rejuvenation

For the most part, tissue repair has the trouble to have a real existence quality and endurance of patients. In the event that our body's fix limit is debilitated or overpowered it prompts constant and fibrotic recuperating. One of the notable uses of regenerative prescription is the substitution of harmed or matured tissues into utilitarian tissues which are the characteristic fix program of our body. e.g., fiery, invulnerable, and fibrotic reactions. Yet at the same time, the riddle in regenerative medication is the correlation of people during development wherein the lower creatures can recover entire organs.

Track 18: Medical Devices and Artificial Organs

Improved health care has resulted in an increased life span for the general population and, when coupled with a growing shortage of donor organs, makes it clear that organ assistance and substitution devices will play a larger role in managing patients with end-stage disease by providing a bridge to recovery or transplantation. (In the U.S. alone, the annual need for organ replacement therapies increases by about 10 percent each year.)The good news is that the field of medical device and artificial organ development is redefining what is believed to be possible for augmenting or replacing organ function.

Track 19: Novel Technologies

Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self-renewal and multilineage  differentiation. Stem cells survive well and show stable division in culture, making them ideal targets for in vitro manipulation.

Track 20: Clinical Trials on Regenerative Medicine

After many years of basic research, regenerative medicine is now beginning to represent a valuable tool to cure several clinical conditions in both acute injuries and chronic diseases. The aim of this study is to update current clinical applications of some selected organs and pathologies which may benefit from regenerative medicine.

Track 21: Biomaterials and Stem Cells in Regenerative Medicine

Biomaterials and Stem Cells in Regenerative Medicine explore a range of applications for biomaterials and stem cell therapy and describes recent research on suitable cell scaffolds and substrates for tissue repair and reconstruction.

Track 22: Applications in Nanotechnology Cellular Plasticity And Reprogramming

Track 23: Stem Cells and Veterinary Applications

The stem cell field in veterinary medicine continues to evolve rapidly both experimentally and clinically. Stem cells are most commonly used in clinical veterinary medicine in therapeutic applications for the treatment of musculoskeletal injuries in horses and dogs. New technologies of assisted reproduction are being developed to apply the properties of spermatogonial stem cells to preserve endangered animal species.same methods can be used to generate transgenic animals for production of pharmaceuticals or for use as biomedical models.

Track 24: Regulatory and Reimbursement Issues

 

Market Analysis

Global Stem Cell & Regenerative Medicine Market is expected to grow at a significant pace in future. A number of factors such as increasing disease incidence rates across the globe for diabetes, cardio-vascular diseases such as stroke, hypertension, etc., cancers that are difficult to treat and/or recover from post treatment, neurodegenerative diseases such Parkinson's disease, Alzheimer’s Disease etc., along with a rising geriatric population have resulted in an increasing demand for more efficient therapeutic strategies, one of which is stem cell therapy for regenerative medicine.

On the basis of regional platform, global stem cell and regenerative medicine market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North-America holds the highest shares in global stem cell and regenerative medicine market followed by Europe due to growth and expansion of pharmaceutical industry in the region. Globally, Asia Pacific is expected to see highest compound annual growth rate and is showcasing huge potential for the stem cell manufacturers to expand and strengthen their business in the region. This is due to the highest population along with increasing rate of cost efficient therapies in this region compared to the rest of the world. This rapid growth is mostly due to escalation of medical tourists from Europe & America who are attracted by lower prices for procedures, highly skilled medical professionals & smaller waiting list in countries such as China & India

The worldwide Stem cell & regenerative medicines market is functional with several parameters like product type, application, sources, geography and users.  In focused to the product type stem cells market is divided into human embryonic stem cells, adult stem cells, IPsec’s, etc. Whereas, regenerative medicines applied the potential of these stem cells to regenerate, repair & replace tissues or the organ which are affected due to injury, natural aging process, and some diseases.

These novel approaches are able to restore the performance of cells & tissues and applied in broad range of fields starting form Tissue Engineering to cosmetic surgery therefore, now it seeks the central attraction of researchers to focuses on the new technologies like Utilization of Nano-materials in immunomodulation, drug delivery to make the growth in regenerative medicines market and blend it with stem cell culture to open new insights, possibilities which can bring evolution in the field of medicine.

Raw Material Analysis for stem cell Market

The regenerative medicine market is broadly divided into three categories namely biologically derived materials, synthetic materials, and genetically engineered materials. The Synthetic materials and genetically engineered materials have high demands in the market due to its higher efficiency as compared to other naturally derived materials. Synthetic materials have used hydrogel in tissue engineered scaffolds.  While Genetically Engineered materials designed in vitro condition with desired gene and potentials. Financially investment for Stem cell and Regeneration Medicine are done by private inventors, and publicly traded stock as well as Government as these research holds the Possibility to Treat numerous Number of Diseases.

Cosmeceuticals Market:

Stem cell Culture Is also used in the field of Plastic and Cosmetic surgery to Remove wrinkles and different ageing issue .As these market is associated with fiction world it will contribute a good amount in the economy and growing rapidly .The market was evaluated at $42.24 billion in 2016 and is expected to reach a value of $68.72 billion by 2022, witnessing a CAGR of 8.52% during the predicted period, 2017-2022.

Cosmeceuticals are the emerging market and so there are lots of opportunities lies in the market that is needed to be explored. North America has been declared as the second largest in the market of cosmeceuticals that has estimated for a share of 31% approx. in 2016.

The United States is the major industry for the organic and in North America natural cosmetic products which shares 85% approx. in 2016 with a market value of $10.62 billion. Whereas, the Asia Pacific is the third largest industry for skin care products market which estimated a share of 22% approx. in 2016.

Market Study of Stem Cells & Regenerative Medicine:

Europe: The regenerative medicine & stem cells market is expected to reach USD 13.578 billion by 2022 from USD 5.06 billion in 2016 at a CAGR of 21.80% during the period 2016-2022.

Middle East: The regenerative medicines market is expected $ 40.55 billion revenue in 2022 from $ 17.03 billion revenue in 2016.

USA: The regenerative medicine & stem cell market is assuming to reach $38.70 billion by the year 2022 from $ 13.33 billion in 2016 at a CAGR of 23.56%.

 

Past Conference Report

Stem Cell Conference 2019

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date August 24-25, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Molecular Biomarkers & Diagnosis Journal of Tissue Science & Engineering Journal of Molecular and Genetic Medicine

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by